The Digital Apothecary

JULY 10, 2016

The Premise It comes as no surprise that with all the hype surrounding the use of technology to transform healthcare, that companies (startups & Pharma) are looking to transform traditional medication use. As a pharmacist, this is perhaps the biggest interest I have in the Digital Health sphere, as I feel it may have the largest impact on my profession, and role as an educator.

Diabetes 130

Diabetes Pharmaceutical Companies Pharmaceutical Companies Hospitals 130

pharmaphorum

JULY 12, 2016

Sanofi Pasteur MSD is transforming its commercial organisation and remodeling its approach to customer engagement. Hear from Sanofi Pasteur MSD’s Alexandre Gultzgoff, Deputy Director, IT, and Antoine Blanc, Commercial Excellence Director, as they share first hand insights on how they are transforming their European commercial operations and improving customer engagement.

52

52

Med Ed 101

JULY 10, 2016

Selection of antipsychotics is challenging, and in my experience, you never know for sure which medication will work for each patient. Here’s a few important clinical pearls regarding the use of antipsychotics. Typical (1st generation) antipsychotics are generally avoided due to a high incidence of troublesome extrapyramidal side effects (EPS). Haloperidol is the classic example […].

40

40

pharmaphorum

JULY 14, 2016

The pharmaceutical industry is one of the largest contributing industries to the UK’s balance of trade, and the UK Nation Health Service (NHS) is the fifth largest employer in the world. Although the process of exit for the UK from the EU has now to be triggered by invoking article 50, the post-Brexit calendar is a firestorm of uncertainty. The uncertainty could potentially have a chilling effect on global pharma investment in the UK, but are the issues that will impact Pharma - a jewel in the c

40

40

Speaker: Chris Antypas and Josh Halladay

Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.